Kwara, A., Yang, H., Antwi, S., Enimil, A., Gillani, F. S., Dompreh, A., . . . Greenblatt, D. J. (2018). Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old. Antimicrob Agents Chemother.
Citação norma ChicagoKwara, Awewura, et al. "Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy On Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old." Antimicrob Agents Chemother 2018.
Citação norma MLAKwara, Awewura, et al. "Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy On Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old." Antimicrob Agents Chemother 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.